VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
Interstitial lung disease (ILD) encompasses a group of heterogeneous diseases characterised by varying degrees of aberrant inflammation and fibrosis of the lung parenchyma. This may occur in isolation, such as in idiopathic pulmonary fibrosis (IPF) or as part of a wider disease process affecting mul...
Main Authors: | Shaney L. Barratt, Victoria A. Flower, John D. Pauling, Ann B. Millar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/19/5/1269 |
Similar Items
-
Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF)
by: Shaney L. Barratt, et al.
Published: (2018-01-01) -
VEGF isoforms have differential effects on permeability of human pulmonary microvascular endothelial cells
by: Khadija Ourradi, et al.
Published: (2017-06-01) -
Role of vascular endothelial growth factor (VEGF) in diagnosis of pleural effusion of different origins
by: M. Fathy, et al.
Published: (2014-07-01) -
Role of <i>VEGF</i> Polymorphisms in the Susceptibility and Severity of Interstitial Lung Disease
by: Sara Remuzgo-Martínez, et al.
Published: (2021-04-01) -
Role of Vascular Endothelial Growth Factor (VEGF) in Human Embryo Implantation: Clinical Implications
by: Xi Guo, et al.
Published: (2021-02-01)